Over a period of 15 months, 11 patients with phaeochromocytoma underwent retroperitoneoscopic excision of their tumours. Five patients had bilateral tumours. All patients underwent thorough preoperative evaluation and preparation with αand β-blockade. In the majority of the patients a hypertensive response was seen during generation of pneumoretroperitoneum. However, the period of tumour dissection and excision was devoid of large haemodynamic fluctuations. The average time taken was 3.5 to 4 hours per gland. Blood loss in successful laparoscopic excision averaged 240 ml (range 120 to 700 ml). In these patients satisfactory postoperative analgesia could be provided with intramuscular pethidine or intramuscular diclofenac sodium. In three patients the procedure had to be converted to open laparotomy due to haemorrhage. All three patients had preoperative radiological evidence of inferior vena cava and aortic involvement. Patient selection plays an important role in a successful outcome.
Laparoscopic surgery has expanded its scope tremendously since the first laparoscopic cholecystectomy was performed in 1987. Laparoscopic adrenalectomy, first reported by Gagner in 1992 1 , may have numerous advantages over conventional transabdominal adrenalectomy, including less postoperative pain, earlier ambulation and return to normal activity [2] [3] [4] . It has been described as the "standard of care" for adrenalectomy for benign lesions 5, 6 .
Whether a phaeochromocytoma should be removed laparoscopically has been a topic of debate 7 ; however reports of successful laparoscopic adrenalectomy for phaeochromocytoma are on the increase [8] [9] [10] .
We describe our experience of 11 patients with 16 phaeochromocytomas who underwent endoscopic adrenalectomy by the retroperitoneal route.
MATERIALS AND METHODS
From January 1996 to August 1998, 11 patients (eight female and three male) underwent endoscopic adrenalectomy for phaeochromocytoma by the retroperitoneal approach. Five patients had bilateral tumours. The age of the female patients ranged from 13 to 50 years (mean 35 years) and that of the males 25 to 35 years (mean 28 years). Associated systemic disorders included thyrotoxicosis (1), diabetes mellitus (2) and pulmonary tuberculosis and pleural effusion (1) . There were two pairs of siblings with MEN IIa syndrome in this series. Patient data are documented in Table 1 . All patients underwent abdominal computed tomography for tumour location. Haematological investigations, biochemical tests of renal and hepatic function and estimation of 24-hour urinary catecholamine excretion were done in all patients. All patients also had electrocardiography (ECG), Holter monitoring, echocardiography and retinoscopy. Five patients had left ventricular hypertrophy; among these, two had evidence of left ventricular dysfunction.
Preoperative drug therapy (Table 1) included a combination of α-blocker (prazosin, terazosin) and a β-blocker (atenolol). In addition some patients required enalapril, nifedepine or amlodipine for adequate control of blood pressure.
Oral diazepam and antihypertensive medications were given to all patients two hours before surgery; intramuscular (IM) pethidine 1.0 to 1.5 mg/kg and promethazine 25 mg were administered 45 to 60 minutes before surgery.
Pulse oximetry, ECG and direct arterial pressure monitoring were instituted before induction of anaesthesia. End-tidal CO 2 (P ET CO 2 ) and central venous pressure monitoring were established after intubation; a urinary catheter and nasogastric tube were inserted after induction was completed. Pulmonary artery catheterization was not used in any patient.
Anaesthesia was induced with 3 to 5 mg/kg of thiopentone IV in all patients. Thiopentone was followed by 2 mg/kg of lignocaine and 0.5 mg/kg of pethidine IV. Tracheal intubation was facilitated by 0.1 mg/kg of vecuronium and was performed after ventilating the lungs with 3 to 4% isoflurane (inspired) for five minutes. Esmolol boluses (0.5 mg/kg; range 25 to 100 mg) and/or nitroglycerine (GTN) infusion (0.05%; range 2 to 5 mg) were used during induction if heart rate (HR) increased to above 100 beats per minute (bpm) or if systolic blood pressure (SBP) increased to above 150 mmHg. Isoflurane was used for maintenance in an inspired concentration of 2 to 4%, delivered through a closed circuit in 60% nitrous oxide in oxygen.
The patients were positioned in the lateral position with the side to be operated uppermost after haemodynamic parameters had been stabilized. The retroperitoneal insufflation pressure was kept at 12 to 14 mmHg.
Acute intraoperative rises in SBP were, in most instances, controlled by increasing isoflurane concentration. With tumour dissection and manipulation visible on the monitor, we were able to predict blood pressure rises in most circumstances. If SBP rise was acute and above 180 mmHg, sodium nitroprusside (SNP) 0.01% infusion (mean dose 1 mg; range 0.1 to 4 mg) was used for a short time. In one of the patients who required conversion to conventional transabdominal adrenalectomy, the total SNP dose used was 55 mg in 10 hours. Episodes of tachycardia (HR>100 bpm) were controlled with esmolol boluses. Vecuronium and pethidine were supple-mented as required. At the end of the procedure residual neuromuscular blockade was reversed and the trachea was extubated if the patient was haemodynamically stable and satisfied routine criteria for extubation. All patients were observed in the intensive care unit (ICU) for 24 hours.
Heart rate and SBP were monitored continuously. The highest values at incision (for trocar insertion), retroperitoneal insufflation, gland manipulation and dissection and following adrenalectomy were compared to baseline (post-intubation) measurements using two-way non-parametric analysis of variance, so that each patient acted as his/her own control.
Blood loss was estimated by measuring the contents of the suction bottle and tubings. The time taken from induction to completion of the procedure was noted.
Postoperatively patients were asked to rate their pain as mild, moderate or severe when they were awake. For mild to moderate pain, diclofenac sodium 75 mg IM was administered. For severe pain pethidine 0.5 mg/kg IV was administered. All patients received IM pethidine (50 or 75 mg) with promethazine (25 mg) on the first night after their surgery. From the next day they received oral/IM NSAIDs if required.
RESULTS
HR and SBP did not change significantly with endotracheal intubation, positioning or skin incision. The mean HR rose significantly only during manipulation of the tumour when compared to postintubation (baseline) heart rate (103±22 versus 83±14, P<0.05; Figure 1 ). In the majority of patients 110±21; 145±44 versus 121±21) but did not obtain statistical significance (Figure 2 ). This rise was abrupt and rapid in the first patient of this series who was normotensive preoperatively and not on αor β-blockade. Two siblings with MEN IIa syndrome who were diabetics had a fall in SBP to 70 and 78 mmHg after retroperitoneal insufflation. The mean SBP rose significantly (P<0.05) during manipulation when compared to baseline (postintubation) value (173±34 versus 121±21, Figure 2 ). The rise in SBP observed was frequent, transient and easily controlled. Maximum rises in SBP occurred when the gland had to be compressed against the diaphragm in order to secure haemostasis. After the last vascular connection was clipped and divided, SBP significantly decreased from 173±34 mmHg to 112± 19 mmHg (P<0.05, Figure 2 ). It was easy to taper off vasodilators and isoflurane by watching the progress of surgery on the monitor.
Mean blood loss was 240±200 ml in the patients who underwent successful retroperitoneoscopic excision of phaeochromocytoma (range 80 to 700 ml). In three patients, where the procedure was converted to open laparotomy, loss was very high (2000±700 ml; range: 1.5 to 3.5 litres). The patient who had the maximum blood loss (patient 11) had bilateral tumours extending along the organ of Zuckerkandl and adherent to the aorta and inferior vena cava (IVC).
The average time taken (per gland) for excision was 3.5 to 4 hours. When awake, six out of eight patients who had undergone successful retroperitoneoscopic removal of phaeochromocytoma complained of mild to moderate pain. Two patients had severe pain and required IV pethidine. All patients were comfortable with one dose of intramuscular pethidine at night on the day of surgery and one to two doses of IM diclofenac sodium (75 mg) the next day. In three patients who required conversion to open laparotomy, the large abdominal incisions required more extensive pain control techniques. Two patients had an epidural catheter inserted after the procedure and received epidural morphine for three to five days and one patient was managed with morphine infusion.
All patients who underwent successful retroperitoneoscopic adrenalectomy resumed oral fluids on the morning after surgery, except for one patient who required postoperative mechanical ventilation. They were able to ambulate on the same day. Their average stay in the hospital was three days.
Two of the three patients who had more extensive (open) surgery required mechanical ventilation overnight. One patient who underwent successful bilateral retroperitoneoscopic adrenalectomy which took eight hours, developed pulmonary oedema towards the end of the procedure and was mechanically ventilated overnight. This patient otherwise made an uneventful recovery.
DISCUSSION
This case series illustrates some of the potential problems that the anaesthetist may face during management of laparoscopic excision of phaeochromocytoma.
The patients usually displayed a hypertensive response during the insufflation of the retroperitoneal space. Though this rise was very rapid (similar to that reported by Heintz 11 ) and necessitated vasodilator therapy in the majority of patients (n=8), it was not statistically significant. Giebler 12 adrenalectomy in the prone position reported that SBP did not rise to more than 160 mmHg. Fernandez-Cruz 13 and more recently Joris et al 14 reported a significant increase in plasma catecholamine concentrations and cardiac output during pneumoperitoneum. The surgical approach in both these series was transabdominal, compared to the retroperitoneal approach in our series. The amount of carbon dioxide needed to insufflate and maintain the retroperitoneal pocket is less than that required for peritoneal insufflation in the transabdominal approach. This fact may have been responsible for the non-significant rise in blood pressure during insufflation.
In two of our patients who had MEN IIa syndrome and diabetes mellitus, the SBP fell during retroperitoneal insufflation. This could possibly be attributed to diabetic autonomic neuropathy.
The period of tumour dissection and manipulation was remarkable for its haemodynamic stability. The frequent peaks in SBP were very transient and could be easily controlled by increasing the concentration of inspired isoflurane. Since the tumour was mostly handled by fine instruments, at times the blood pressure rise could even be pre-empted by watching the monitor. On the whole this period was devoid of the marked haemodynamic swings which characterize the conventional transabdominal adrenalectomy for phaeochromocytoma, as reported by others [15] [16] [17] . None of the patients had supraventricular or ventricular dysrhythmias, as have been reported during conventional transabdominal approach for phaeochromocytoma 16, 18 . In our series, large SBP rises necessitating short infusions of SNP generally occurred when the gland had to be steadied against the diaphragm for haemostasis. Nicardipine infusion has been used 14 to control rises in SBP during adrenal manipulation. We used SNP due to its rapid onset and brief duration of action. Some authors 7,8 reported a significant incidence of hypertensive crisis during laporoscopic adrenalectomy. After excision of the tumour, no patient had hypotension requiring vasopressor therapy.
In our series, conversion from retroperitoneoscopic to conventional transabdominal adrenalectomy resulted in a more complicated perioperative course (prolonged surgery, greater blood loss, greater haemodynamic disturbances, increased requirement for mechanical ventilation and analgesic regimens).
Last, but not least, is the ease of management of postoperative pain after successful retroperitoneoscopic adrenalectomy, due to four or five small trocar incisions. With the retroperitoneal approach the characteristic discomfort associated with pneumo-peritoneum (as seen with laparoscopic cholecystectomies) was conspicuously absent. This low pain incidence has also been reported by other authors 10, 19 .
In conclusion, successful retroperitoneoscopic adrenalectomy for phaeochromocytoma appears to have advantages (better intraoperative haemodynamic stability, reduced blood loss and less postoperative pain and discomfort). However these patients need equally intensive monitoring, adequate vascular access and availability of large volumes of blood and related products, as for an open procedure. The surgeon's experience and patient selection contribute significantly to the outcome. The likelihood of conversion to an open procedure (in our small series, 25%) remains a possibility. The anaesthetist actually now has an extra monitor to watch and it adds considerably to the stress associated with managing a phaeochromocytoma. If the tumours are bilateral, it is necessary to change the patient's position for the contralateral side; one may even have to change the arterial cannulation site, which we had to do in two patients.
Though retroperitoneoscopic adrenalectomy offers definite advantages over the conventional transabdominal approach, the period of retroperitoneal insufflation requires vigilance and hypertensive responses appropriately treated. Diabetic patients may show a fall in blood pressure. Watching the progress of surgery on the monitor may aid in anticipating and treating hypertensive episodes and to taper vasodilators towards the completion of excision.
